Lithium-bearing geology. Source: Adobe Stock
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

It’s a hard time to be a Core Lithium (ASX:CXO) shareholder, if you’re one of the unlucky ones still holding on.

Because while the company may have made a few million in Q1 – Core says it shipped enough spodumene, and has enough fines leftover, to make A$25M – it’s running off stockpiles.

Back in January of 2024, when lithium prices fell nearly -90% YoY, Core made the devastating decision to stop mining altogether.

And in Q1 it’s got enough there for $25M, sure – but shareholders aren’t convinced.

The company’s shares were down -3.45% to 14cps in the first twenty minutes of trade, according to Cboe live pricing.

What’s more, Core expects its stockpiles to be depleted by ‘mid-2024’ – in other words, the start of FY25. It will, by that time, have restarted the Finniss operation.

What exactly will happen then isn’t particularly obvious. Core had 139,000/t of stockpiles left on March 31 and $80.4M in cash.

That $80.4M figure was “impacted by shipment timing, QP payments and settlement of the grants mining contract.”

Spodumene concentrate production was also down -14% QoQ which the company blamed on a 5-day shutdown for maintenance.

Newly found interim CEO Doug Warden described the quarter as “challenging.”

“It was pleasing to see the continued improvement in recoveries as processing of ore stockpiles continued during the quarter,” Warden said.

“Whilst processing of the remaining ore stockpiles is expected to be completed by June 2024, the Company has developed plans to restart of the Finniss operation, should the lithium price increase sufficiently to generate positive cash flow.”

Core last traded at 14cps – much like the lithium price, its returns are down near -85% YoY.

CXO by the numbers
More From The Market Online
The Market Online Video

ASX Market Close: Bourse finishes week on a high as Wisetech pummeled | November 22, 2024

The ASX200 closed up 0.85% at 8,393 points. Economists increasingly expect interest rates in Australia won’t…
The Market Online Video

HotCopper Highlights: Your most watched stocks for Week 47, 2024

In this segment we’ll look at the top stocks HotCopper users have been watching, and discussing,…
Nuclear explosion mushroom cloud concept

Week 47 Wrap: HotCopper users’ most watched; Brent lifts on Putin’s scary letter; RFK dents CSL

Welcome to the end of another week. Let's start with what HotCopper users have been watching…
Dale Gillham's photo, and wording 'Words from Wealth Within's Chief Analyst Dale Gillham.

Dale Gillham’s weekly wrap: Sigma-Chemist Warehouse merger creates pharma powerhouse

The $8.8 billion dollar merger between Sigma Healthcare and Chemist Warehouse is poised to reshape the Australian pharmacy landscape, consolidating power in th…